Barclays
PDSB icon

Barclays’s PDS Biotechnology PDSB Stock Holding History

Barclays’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513 Buy
+582
New +$618 ﹤0.01% 5005
2024
Q3 		– Sell
-1
Closed -$3 – 5430
2024
Q2 		$3 Sell
1
-19,765
-100% -$63.2K ﹤0.01% 4795
2024
Q1 		$78.3K Sell
19,766
-18,636
-49% -$96K ﹤0.01% 4516
2023
Q4 		$191K Buy
38,402
+33,488
+681% +$166K ﹤0.01% 4439
2023
Q3 		$24.8K Sell
4,914
-657
-12% -$3.6K ﹤0.01% 4125
2023
Q2 		$28K Sell
5,571
-33,684
-86% -$221K ﹤0.01% 4057
2023
Q1 		$241K Buy
+39,255
New +$321K ﹤0.01% 3683
2021
Q4 		– Sell
-14,728
Closed -$219K – 4578
2021
Q3 		$219K Buy
+14,728
New +$184K ﹤0.01% 3573
2020
Q3 		– Sell
-37
Closed – – 5482
2020
Q2 		$0 Buy
+37
New +$41 ﹤0.01% 6088
2019
Q4 		– Sell
-1
Closed – – 6699
2019
Q3 		$0 Buy
+1
New +$6 ﹤0.01% 7024
2018
Q2 		– Sell
-219
Closed -$5K – 7203
2018
Q1 		$5K Buy
219
+57
+35% +$15.3K ﹤0.01% 6793
2017
Q4 		$31K Buy
162
+139
+604% +$28K ﹤0.01% 6044
2017
Q3 		$5K Buy
23
+7
+44% +$1.45K ﹤0.01% 6421
2017
Q2 		$3K Buy
16
+12
+300% +$2.36K ﹤0.01% 6354
2017
Q1 		$1K Sell
4
-16
-80% -$3.17K ﹤0.01% 6609
2016
Q4 		$5K Buy
20
+15
+300% +$3.41K ﹤0.01% 6138
2016
Q3 		$1K Sell
5
-194
-97% -$38.4K ﹤0.01% 6417
2016
Q2 		$40K Buy
+199
New +$35.2K ﹤0.01% 4954
2016
Q1 		– Sell
-6
Closed -$1K – 6370
2015
Q4 		$1K Buy
+6
New +$1.93K ﹤0.01% 5837

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Barclays's PDSB Position: Q2 2026 in Review

Barclays opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 582 shares worth $513. The stake represents ﹤0.01% of the portfolio and ranks #5005 among its holdings. This is a return to the name: Barclays previously reported a position in PDSB as recently as Q2 2024.

Barclays first reported a position in PDSB in Q4 2015 and has held it in 19 quarters since. The position peaked at $241K in Q1 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Barclays held 582 shares of PDS Biotechnology worth $513 as of Q2 2026.
  • PDS Biotechnology was a new Barclays position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5005 holding.
  • Barclays first reported a position in PDS Biotechnology in Q4 2015 and has held it in 19 quarters since.
  • Barclays's PDS Biotechnology position peaked at $241K in Q1 2023.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.